Principia Biopharma Inc (PRNB) Stock Price, Quote, News and Overview
NASDAQ:PRNB - Nasdaq -
PRNB Quote, Performance and Key Statistics
100.05
+0.1 (+0.1%)
The current stock price of PRNB is 100.05 null. In the past month the price decreased by -0.81%. In the past year, price increased by 248.73%.
About PRNB
Company Profile
Principia Biopharma Inc. is a clinical stage biopharmaceutical company. It offers reversible covalent small molecule drugs for the treatment of cancers. The company's product pipeline consists of PRN1008, PRN1371 and PRN2246 which are in clinical stage. Principia Biopharma Inc. is based in San Francisco, United States.
Company Info
Principia Biopharma Inc
220 East Grand Avenue
SOUTH SAN FRANCISCO CA 94080
CEO: Martin Babler
Phone: 650-416-7700
Principia Biopharma Inc / PRNB FAQ
What is the stock price of Principia Biopharma Inc today?
The current stock price of PRNB is 100.05 null. The price increased by 0.1% in the last trading session.
What is the ticker symbol for Principia Biopharma Inc stock?
The exchange symbol of Principia Biopharma Inc is PRNB and it is listed on the Nasdaq exchange.
On which exchange is PRNB stock listed?
PRNB stock is listed on the Nasdaq exchange.
What is Principia Biopharma Inc worth?
Principia Biopharma Inc (PRNB) has a market capitalization of 3.32B null. This makes PRNB a Mid Cap stock.
What are the support and resistance levels for Principia Biopharma Inc (PRNB) stock?
Principia Biopharma Inc (PRNB) has a support level at 100.04 and a resistance level at 100.66. Check the full technical report for a detailed analysis of PRNB support and resistance levels.
Should I buy Principia Biopharma Inc (PRNB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PRNB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PRNB, evaluating the profitability, health, valuation and growth aspects
- Principia Biopharma Inc (PRNB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Principia Biopharma Inc (PRNB) Sales and EPS estimates to see what analysts future expectations are.
- Principia Biopharma Inc (PRNB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Principia Biopharma Inc (PRNB) Insider and Institutional Ownership to learn about the owners and their transactions.
- Principia Biopharma Inc (PRNB) Stock Chart to make your own analysis
- Principia Biopharma Inc (PRNB) Latest news and press-releases to stay up to date.
Does Principia Biopharma Inc (PRNB) stock pay dividends?
PRNB does not pay a dividend.
What is the Price/Earnings (PE) ratio of Principia Biopharma Inc (PRNB)?
Principia Biopharma Inc (PRNB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.41).
PRNB Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to PRNB. When comparing the yearly performance of all stocks, PRNB is one of the better performing stocks in the market, outperforming 98.45% of all stocks.
PRNB Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PRNB. While PRNB has a great health rating, there are worries on its profitability.
PRNB Financial Highlights
Over the last trailing twelve months PRNB reported a non-GAAP Earnings per Share(EPS) of -2.41. The EPS decreased by -3112.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -137.82% | ||
| ROA | -17.85% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
PRNB Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to PRNB. The Buy consensus is the average rating of analysts ratings from 7 analysts.